1Zaffanello M, Brugnara M, Fanos V, et al. Prophylaxis with AT IIl for thromboembotism in nephrotic syn drome:why should it be done? [J]. lnt Uroi Nephrol, 2009,41(3):713-716.
2Sirolli V, Ballone E, Garofalo D, et al. Platelet activation markers in patients with nephrotie syndrome. A compara tive study of different platelet function tests [J]. Neph ron,2002,91(3) :424-430.
3Bramham K, Hunt BJ, Goldsmith D. Thrombophilia of Nephrotie Syndrome in Adults [J]. Clinical Advances in Hematology, 2009,7 (6) : 368-372.
4Ito S, Machida H ,Inaba A, et al. Amelioration of steroids and cyclosporine-resistant nephrotic syndrome by pravas- tatin[J]. Pediatr Nephrol, 2007,22 (4) : 603-606.
5Singhal R,Brimble KS. Thromboembolic complications in the nephrotic syndrome.. Pathophysiology and clinical management[J]. Thromb Res,2006,118(3) :397-407.
6Chang H,Chen YM,Dunn P. Factor VIII inhibitor assoei ated with nephrotic syndrome [J]. Haemophilia, 2007, 13 (6) :766.
7Beheiri A,Langer C,During C,et al. Role of elevated a2- macroglobulin revisited:results of a case-control study in children with symptomatic thromboemholism[J]. J Thromb Haemost,2007,5(6) :1179-1184.
8Kuipers S,Cannegieter SC,Doggen CJ ,et al. Effect of ele- vated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers[J]. Blood,2009,113 (9) :2064-2069.
9Ozkaya O,Bek K,Fisqin T,et al. Low protein Z levels in children with nephrotic syndrome[J]. Pediatr Nephrol, 2006,21(8) :1122-1126.
10Cacciapuoti F. Some considerations about the hypercoagu- lable states and their treatments[J]. Blood Coagul Fibri- nolysis,2011,22(3) :155-159.
